Versant Ventures
Finance · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1 Sansome St Ste 3630, San Francisco, Ca...Phone Number
(415) 801-8100Website
www.versantventures.comRevenue
$20.3 MillionIndustry
About Versant Ventures
Versant Ventures Org Chart
Is Versant Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Versant Ventures has new funding data
Check out if Versant Ventures is spiking on competitors!
Check if Versant Ventures has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Versant Ventures recently announced quarterly report
Product Launch: Get notified when Versant Ventures launches new products
Click to see if Versant Ventures had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Versant Ventures
Website visits: Recent activity has been detected on your website
Versant Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Versant Ventures
Find 2 more new buyers
Compare Similar Companies to Versant Ventures
Compare insights from companies similar to Versant Ventures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Versant Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Versant Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Versant Ventures.
Versant Ventures Tech Stack
A closer look at the technologies used by Versant Ventures
Most Recent Scoops
Versant Ventures News & Media
Switzerland: Granite Bio emerges from stealth with US$100m in funding
Granite Bio emerges from stealth with US$100m in fundingGranite Bio Debuts With $100 Million of Capital
BASEL, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Granite Bio AG, a clinical-stage immunology company, has emerged from stealth with $100 million in funding. This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund, and a $70 million Series B led by Forbion and Sanofi Ventures. Granite’s pipeline features two first-in-class antibodies targeting multiple autoimmune diseases that address large market opportunities. GRT-001 depletes pro-inflammatScaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor
SUNNYVALE, Calif.--(BUSINESS WIRE)--Intuitive Ventures today announced the appointment of Terri Burke, former head medtech investments at Epidarex Capital and a seasoned operator, as Senior Partner and Dr. Ross Jaffe, a co-founder of Versant Ventures, as Venture Advisor. Both medtech veterans, they will help support the continued growth of Intuitive Ventures in investing in start-ups reimagining the future of minimally invasive care. With more than two decades of medtech investing and operationAntag Therapeutics Closes €80 Million Series A Financing | News & Events | Goodwin
The Goodwin Life Sciences team advised a syndicate of investors on their investment into the €80 Million Series A Financing of Antag Therapeutics.
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Versant Ventures
Versant Ventures partners with exceptional entrepreneurs to build and fund innovative biotechnology companies around the world. With over $5.5 billion under management, they have a strong track record that includes over 50 IPOs and M&A transactions. Their experienced team boasts extensive backgrounds in venture capital, pharmaceuticals, and biotech... Read More
